Skip to main content
AP Healthcare Inc. logo

AP Healthcare Inc. — Investor Relations & Filings

Ticker · 109960 ISIN · KR7109960005 KO Human health and social work activities
Open in API
Filings indexed 263 across all filing types
Latest filing 2026-02-23 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 109960

About AP Healthcare Inc.

https://aphealthcare.org/

APTOCROM Inc., formerly known as AP Healthcare Inc., is a company engaged in the distribution and sale of pharmaceutical products. Its core business involves pharmaceuticals, and it has been involved in the commercialization of biosimilar products through partnerships with other biotechnology firms. The company has also announced plans to enter the virtual asset business.

Recent filings

Filing Released Lang Actions
주권매매거래정지 (자본감소)
Share Issue/Capital Change Classification · 1% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for a specific company due to capital reduction. It cites regulatory rules (KOSDAQ market disclosure regulations) and provides specific dates and reasons for the suspension. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or share buybacks, it is classified as a general regulatory filing.
2026-02-23 Korean
주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding a 'Capital Reduction Decision' (감자 결정). This involves a corporate action affecting the company's capital structure (share consolidation). Since it pertains to a change in capital structure and is a formal regulatory filing regarding a specific corporate event, it falls under the 'Capital/Financing Update' category.
2026-02-23 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by the company. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and capital reduction) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of the upcoming vote.
2026-02-23 Korean
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득 (제6회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the acquisition of bonds before maturity (specifically, Bond with Warrant, BW). It details the specific bond series, acquisition amount, reason (put option exercise), and future handling (cancellation). This falls under capital structure changes and financing updates, specifically related to debt management. Given the specific nature of bond buybacks/repayments, it fits best under the 'CAP' (Capital/Financing Update) category.
2026-01-26 Korean
[기재정정]주권관련사채권의취득결정 (제27회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing titled 'Correction Report' (정정신고) regarding the 'Acquisition of Equity-Related Bonds' (주권 관련 사채권의 취득결정). It details specific changes to the maturity date and conversion period of a convertible bond (CB) issuance. This type of document is a standard corporate disclosure filed with financial regulators (such as the DART system in Korea) to update investors on material changes to financing terms. It falls under the category of capital and financing updates.
2026-01-20 Korean
[기재정정]투자판단관련주요경영사항 ((주)에이프로젠의 AP096, Adalimumab Biosimilar 개발을 위한 투자금 분담 계약 체결)
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details a change in the timeline for a capital investment contract related to a biosimilar development project. Since it is a formal regulatory disclosure of a material business event that does not fit into specific categories like M&A or Share Issues, it is classified as a general Regulatory Filing (RNS).
2025-12-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.